首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Simultaneous determination of bilirabin and its giucuronides ie liver microsomes aed recombieant UGT1A1 enzyme incubation systems by HPLC method and its application to bilirabin glucuroeidation studies
【24h】

Simultaneous determination of bilirabin and its giucuronides ie liver microsomes aed recombieant UGT1A1 enzyme incubation systems by HPLC method and its application to bilirabin glucuroeidation studies

机译:通过HPLC法同时测定肝脏微核苷酸IE肝微粒体AED Recombieant UGT1A1酶孵育系统及其在血曲线葡萄糖素化研究中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

Bilirubin, an important endogenous substances and liver function index in humans, is primarily eliminated via UGT1A1 -catalyzed glucuronidation. Instability of bilirubin and its giucuronides brings substantial technical challenges to conduct in vitro bilirubin glucuronidation assay. In the present study, we developed a simple and robust HPLC method for simultaneous determination of unconjugated bilirubin (UCB) and its multiple giucuronides, i.e. bilirubin monoglucuronides (BMGs, including BMG1 and BMG2 isomers) and diglucuronide (BDG) in rat liver microsomes (RLM), human liver microsomes (HLM) and recombinant human UGT1A1 enzyme (UGT1A1) incubation systems, and applied it to study in vitro bilirubin glucuronidation. UCB, BMG1, BMG2, BDG and their isomers in the incubation mixtures were successfully separated using a C18 column with UV detection at 450 nm and mobile phase consisted of 0.1% formic acid in water and acetonitrile by a linear gradient elution program. Assay linearities of bilirubin were confirmed in the range 0.01-2 muM. Precision of UCB, BMG1, BMG2 and BDG (n = 5) at low, medium and high concentration was within the range of RSD 0.4-3.7%, accuracy expressed in the mean assay recoveries of them (n = 5) ranged from 92.8 ± 1.5% to 104.3 ± 2.2% for intra- and inter-day assays and the mean extraction recoveries of them (n = 5) were above 91.5 ± 1.0%. Stability of bilirubin and its giucuronides was satisfactory at 37 °C in the incubation solutions during the reaction (30 min), 25degC for 24 h and -70 °C for 7 d in the processed incubation samples with methanol. Furthermore, we established stable, reliable in vitro incubation systems and optimized the incubation conditions to characterize the kinetics of bilirubin glucuronidation by RLM, HLM and UGT1A1, respectively. The kinetic parameters of formation of total bilirubin giucuronides (TBG, the sum of BMG1, BMG2 and BDG) were as follows: K_m of 0.45 ± 0.016,0.40 ± 0.022,0.44 ± 0.018 muM, V_(max) of 2.65 ± 0.057,1.86 ± 0.029,2.95 ± 0.036 nmoi/mg/min, CL_(int) of 5.92 ±0.22,4.70 ±0.079,6.72 ±0.27 mL/mg/min by RLM, HLM and UGT1A1, respectively. Bilirubin glucuronidation obeyed the Hill equation by RLM and the Michaelis-Menten equation by HLM and UGT1A1 in the range of substrate concentration selected, respectively. In addition, the relative proportions between BDG and BMGs were in connection with enzyme sources (e.g. RLM, HLM and UGT1A1) and bilirubin concentration.
机译:胆红素,一种重要的内源性物质和肝功能指数,主要通过UGT1A1 -cAtalyzed葡萄糖醛化消除。胆红素及其Giucuronides的不稳定性带来了体外胆红素葡萄糖醛酸化测定的实质性技术挑战。在本研究中,我们开发了一种简单且鲁棒的HPLC方法,用于同时测定未缀合的胆红素(UCB)及其多种GiCulonides(即胆红素单葡糖苷(BMG)(包括BMG1和BMG2异构体)和Diglucuronide(BDG)中的胆汁尿嘧啶(BDG)(RLM ),人肝微粒体(HLM)和重组人UGT1A1酶(UGT1A1)孵育系统,并应用于体外胆红素葡萄糖醛酸的研究。在孵育混合物中使用C18塔在孵育混合物中使用C18塔成功分离了UCB,BMG1,BMG2,BDG和它们的异构体,在450nm处,流动相通过线性梯度洗脱计划在水和乙腈中组成0.1%甲酸。测定胆红素的线性在0.01-2毫米的范围内得到证实。在低,培养基和高浓度下UCB,BMG1,BMG2和BDG(n = 5)的精度在RSD 0.4-3.7%的范围内,在其平均测定回收中表示的精度(n = 5)范围为92.8±用于和日间测定的1.5%至104.3±2.2%和它们的平均提取回收率(n = 5)高于91.5±1.0%。在与甲醇的加工孵育样品中,在反应(30分钟),25dEGC,24小时,25dEGC,25dEGC,25dEGC,在加工培养样品中,在34小时和-70℃下,在37℃下,在37℃下,在37℃下,在37℃下令人满意,在加工后的孵育样品中令人满意。此外,我们在体外培养系统中建立了稳定,可靠,并优化了培养条件,以分别通过RLM,HLM和UGT1A1表征胆红素葡萄糖糖的动力学。总胆红素Giucuronides的形成动力学参数(TBG,BMG1,BMG2和BDG)如下:K_M为0.45±0.016,0.40±0.022,0.44±0.018毫米,V_(最大)为2.65±0.057,1.86 ±0.029,2.95±0.036 NMOI / mg / min,CL_(int)分别为5.92±0.22,4.70±0.079,6.72±0.27ml / mg / min,分别通过RLM,HLM和UGT1A1。胆红素葡萄糖化分别遵守了RLM的山丘方程,并分别在选择的底物浓度范围内通过HLM和UGT1A1的MICHAELIS-MENTen方程。此外,BDG和BMG之间的相对比例与酶来源(例如RLM,HLM和UGT1A1)和胆红素浓度有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号